Percutaneous Microwave Ablation is Comparable to Cryoablation for the Treatment of T1a Renal Masses: Results From a Cross-Sectional Study.

[1]  J. D. Del Pizzo,et al.  Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center. , 2021, Clinical imaging.

[2]  P. Umari,et al.  Oncological outcomes of active surveillance and percutaneous cryoablation of small renal masses are similar at intermediate term follow-up. , 2021, Minerva urology and nephrology.

[3]  P. Umari,et al.  Needle tract seeding after percutaneous cryoablation of small renal masses; a case series and literature review , 2020, Scandinavian journal of urology.

[4]  W. Prevoo,et al.  Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma , 2020, Cardiovascular and Interventional Radiology.

[5]  A. Zisman,et al.  Has Stage Migration in Renal Cancer Run Its Course? A SEER Database Analysis. , 2020, Clinical genitourinary cancer.

[6]  S. Partovi,et al.  Society of Interventional Radiology Position Statement on the Role of Percutaneous Ablation in Renal Cell Carcinoma: Endorsed by the Canadian Association for Interventional Radiology and the Society of Interventional Oncology. , 2019, Journal of vascular and interventional radiology : JVIR.

[7]  J. Durack,et al.  Imaging of Small Renal Masses before and after Thermal Ablation. , 2019, Radiographics : a review publication of the Radiological Society of North America, Inc.

[8]  F. Cobelli,et al.  Percutaneous ablation techniques for renal cell carcinoma: current status and future trends , 2019, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[9]  U. Capitanio,et al.  Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors , 2019, CardioVascular and Interventional Radiology.

[10]  R. Uppot,et al.  Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes. , 2019, Journal of vascular and interventional radiology : JVIR.

[11]  F. Bray,et al.  Epidemiology of Renal Cell Carcinoma. , 2019, European urology.

[12]  P. Shyn,et al.  Image-Guided Renal Interventions. , 2018, The Urologic clinics of North America.

[13]  R. Uppot,et al.  Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center. , 2017, AJR. American journal of roentgenology.

[14]  F. Orsi,et al.  CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma , 2017, CardioVascular and Interventional Radiology.

[15]  S. Stavropoulos,et al.  Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. , 2012, Journal of Vascular and Interventional Radiology.

[16]  R. Thompson,et al.  Complications following 573 percutaneous renal radiofrequency and cryoablation procedures. , 2012, Journal of vascular and interventional radiology : JVIR.

[17]  Christopher L Brace,et al.  Microwave tumor ablation: mechanism of action, clinical results, and devices. , 2010, Journal of vascular and interventional radiology : JVIR.

[18]  Christopher L Brace,et al.  Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? , 2009, Current problems in diagnostic radiology.

[19]  C. Tilquin,et al.  Risk Adjustment in Outcome Assessment: the Charlson Comorbidity Index , 1993, Methods of Information in Medicine.